I believe there will be a partnership between BP and NWBO. Don't know when or how much $$$ will be involved. But, without any doubt, I can say that if the tld is what we suspect (or as Anders2211 says, turn out to be "superb"), owning NWBO stock will be THE investment of our life time.
PB will have to partner with nwbo as a DCVax-L combo would increase the effectiveness of PB's most profitable products. Without DCVax-L their product(s) could be rendered obsolete. For someone to suggest that PB would not partner with NWBO until after approval is asinine, particularly when there appears to be some coordination between Merck and NWBO already (i.e. Duffy's temporary assignment at NWBO just prior to the completion of the p3 trial SAP). Likewise to suggest that NWBO's MC will be around $5/$6 billion even after approval is a bit crazy too no matter how one goes about determining mC value for NWBO.
We are in agreement, although I don't think it will 5-10 years for NWBO's market cap to grow way beyond $6 billion even if it rejects a buyout or giving significant control to BP in a partnership.
But what do I know....
Market Data 
Markets 
AI
